Zevra Therapeutics (ZVRA) Minority Interest (2014 - 2015)

Zevra Therapeutics (ZVRA) has 2 years of Minority Interest data on file, last reported at $28.2 million in Q1 2015.

• Quarterly Minority Interest changed N/A year-over-year to $28.2 million in Q1 2015, while the trailing twelve-month figure through Mar 2015 was $28.2 million (changed N/A YoY) and the FY2014 annual result came in at $24.2 million, changed N/A from the prior year.
• Minority Interest grew to $28.2 million in Q1 2015, from $24.2 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $28.2 million in Q1 2015 to a low of $24.2 million in Q4 2014.